SCHEMBL6779112

SCHEMBL6779112

COc1cccc(N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc2SCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 1/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ LPAR1 Q92633 4/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ SAE1 Q9UBE0 1/20 0.43
▸ UBA2 Q9UBT2 1/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HSD17B2 P37059 2/20 0.41
▸ HSD17B1 P14061 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MLNR O43193 2/20 0.40
▸ MAPKAPK2 P49137 1/20 0.40
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6781090 0.90 MTNR1A (0.41) PTGESALOX5LPAR1RAB9ANPC1
SCHEMBL6779164 0.89 KMT2A (0.45) PTGESALOX5LPAR1KMT2ANPSR1
SCHEMBL6784314 0.89 HIF1A (0.46) PTGESALOX5LPAR1KMT2AMAPT
SCHEMBL6780285 0.87 KDM4E (0.41) PTGESALOX5LPAR1KMT2ANPSR1
SCHEMBL6775398 0.80 KMT2A (0.46) KMT2ARAB9ANPC1MEN1ALDH1A1
SCHEMBL6778194 0.79 TSHR (0.44) LPAR1KMT2AMAPTKDM4EMEN1
SCHEMBL6784549 0.78 LTB4R2 (0.48) PTGESALOX5LPAR1KMT2AGAA
SCHEMBL6774704 0.78 TSHR (0.47) LPAR1KMT2AMAPTRAB9AMEN1
SCHEMBL6773941 0.77 LMNA (0.61) KMT2ARAB9ANPC1MEN1ALDH1A1
SCHEMBL6780300 0.76 LTB4R2 (0.46) PTGESALOX5LPAR1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT PTGES 902/4885ALOX5 1156/4885LPAR1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback